S2Medical AB
Research S2Medical AB (S2M) on Bullrun: market cap SEK 6.25M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerS2M
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencySEK
- Market capSEK 6.25M
- Financial periodFY2025
- RevenueSEK 16.13M
- Revenue growth9.9%
- Net income-SEK 10.09M
- Free cash flowSEK 680.00K
- Gross margin87.0%
Valuation Snapshot
latest market cap is SEK 6.25M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 16.13M | -SEK 10.09M | SEK 680.00K | 87.0% | -0.01 | SEK 910.00K | n/a | SEK 9.88M |
| FY2024 | SEK 14.68M | SEK 4.81M | SEK 5.03M | 94.8% | 0.01 | SEK 1.00M | n/a | SEK 18.72M |
| FY2023 | SEK 7.72M | -SEK 22.71M | -SEK 16.52M | 65.3% | -0.19 | SEK 1.52M | n/a | SEK 1.66M |
| FY2022 | SEK 6.16M | -SEK 29.46M | -SEK 28.34M | 83.9% | -1.24 | SEK 3.72M | n/a | SEK 7.07M |
| FY2021 | SEK 10.63M | -SEK 20.08M | -SEK 19.85M | 66.8% | -1.35 | SEK 9.48M | SEK 210.00K | SEK 14.68M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | SEK 6.25M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About S2Medical AB
S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is S2Medical AB's market cap?
S2Medical AB's market capitalization is SEK 6.25M.
What does S2Medical AB do?
S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery.